Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for IQV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 2.819B
March 31, 2026 2.704B
December 31, 2025 2.654B
September 30, 2025 2.804B
June 30, 2025 2.617B
March 31, 2025 2.762B
December 31, 2024 2.716B
September 30, 2024 2.578B
June 30, 2024 2.44B
March 31, 2024 2.254B
December 31, 2023 2.149B
September 30, 2023 1.962B
June 30, 2023 2.242B
March 31, 2023 2.169B
December 31, 2022 2.26B
September 30, 2022 2.392B
June 30, 2022 2.373B
March 31, 2022 2.583B
December 31, 2021 2.942B
September 30, 2021 3.00B
June 30, 2021 2.73B
March 31, 2021 2.663B
December 31, 2020 1.959B
September 30, 2020 1.792B
June 30, 2020 1.548B
Date Value
March 31, 2020 1.467B
December 31, 2019 1.417B
September 30, 2019 1.251B
June 30, 2019 1.265B
March 31, 2019 1.185B
December 31, 2018 1.254B
September 30, 2018 1.07B
June 30, 2018 1.162B
March 31, 2018 1.096B
December 31, 2017 970.00M
September 30, 2017 1.184B
June 30, 2017 1.008B
March 31, 2017 803.89M
December 31, 2016 860.00M
September 30, 2016 619.26M
June 30, 2016 641.99M
March 31, 2016 652.16M
December 31, 2015 475.69M
September 30, 2015 525.33M
June 30, 2015 379.49M
March 31, 2015 395.84M
December 31, 2014 431.75M
September 30, 2014 391.26M
June 30, 2014 430.68M
March 31, 2014 390.39M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Medpace Holdings, Inc. 752.66M
Charles River Laboratories International, Inc. 582.15M
Moderna, Inc. -1.073B
Fortrea Holdings, Inc. 227.80M
OmniAb, Inc. -17.67M